Toxaphene, a complex mixture of polychloroterpenes and a major insecticide, is mutagenic

Analysis and Characterization of Polychlorinated Hydroxybornanes as Metabolites of Toxaphene Using a Polar Bear Model

Abiotic and biotic transformation of toxaphene (camphechlor) results in the selective enrichment of recalcitrant congeners while other, less persistent compounds of technical toxaphene (CTTs) are degraded. Until now, there has been little knowledge on oxidation transformation of toxaphene. For instance, the existence of hydroxylated CTTs (OH-CTTs) in authentic environmental and food samples has not been proven. For this reason, we synthesized a mixture consisting of tetra- to heptachlorinated OH-CTTs and simplified it by countercurrent chromatography (CCC). Thus, 227 OH-CTTs were detected in the CCC fractions (12 tetra-, 117 penta-, 81 hexa-, and 17 heptachlorinated OH-CTTs), which was >50% more than detected before the fractionation. One CCC fraction consisting of only 18 OH-CTTs was used to develop a sample cleanup method which aimed to remove CTTs, isobaric PCBs, and sample matrix. The final cleanup procedure consisted of (i) gel permeation chromatography (GPC) and adsorption chromatography using (ii) deactivated and (iii) activated silica gel. Hence, up to 320 and 4350 μg/kg lipid weight of octa- and nonachlorinated CTTs were detected in four liver samples and adipose tissue of polar bears, respectively. Furthermore, the presence of one hexachlorinated OH-CTT isomer could be verified in the samples, which was about 1% of the octachlorinated CTTs determined in the liver samples.

Toxic Effects of Toxaphene for Goldfish

Toxaphene is an organochlorine insecticide, widely used in cereals, vegetables, fruits, tea and other pests. However, in killing pests, increasing agricultural production, while toxaphene aquatic creatures threat. In order to enrich aquatic organisms toxicological data, evaluate the risk to aquatic organisms toxaphene healthy growth, we use the traditional toxicological approach to study the toxic effects of toxaphene goldfish (Carassius auratus)'s. Study 5 toxaphene concentration 7d goldfish exposed catalase (CAT), superoxide dismutase (SOD), acetylcholinesterase (TChE), glutathione peroxidase (GSH-PX), malondialdehyde (MDA) effects, the results showed that: toxaphene in 0.1,0.2,0.3,0.4, 0.5 μg / L in five concentrations, these five enzymes promoting effect, with more toxaphene concentration high, goldfish liver CAT activity is stronger, the stronger the brain and liver SOD activity, the activity of the brain TChE weaker, the stronger the brain activity of GSH-PX, and the contrast with the blank, P <0.01, illustrate the five enzymes do toxaphene toxicity testing of biomarkers.

Comparing the mutagenicity of toxaphene after aging in anoxic soils and accumulating in fish

A test program was conducted to evaluate the mutagenicity of toxaphene residuals extracted from aged soils and from fish collected in creeks near a toxaphene-contaminated site. The ultimate objective was to determine if the residual toxaphene congeners were more or less mutagenic than those in technical-grade toxaphene. The study showed that the mutagenicity of the bioaccumulated toxaphene congeners in fish, expressed as colony revertants per microg of residual toxaphene, was no greater than that of technical-grade toxaphene. The mutagenic impact of the toxaphene residuals in aged soil statistically was less than that for technical-grade toxaphene. Two specific congeners, a hexachlorobornane (labeled Hx-Sd) and a heptachlorobornane (labeled Hp-Sd), were found to accumulate over time in both soil and fish extracts, but did not show increased mutagenic impacts relative to that produced by technical-grade toxaphene.

Advances in the environmental analysis of polychlorinated naphthalenes and toxaphene

Recent advances in the analysis of the chlorinated environmental pollutants polychlorinated naphthalenes (PCNs) and toxaphene are highlighted in this review. Method improvements have been realized for PCNs over the past decade in isomer-specific quantification, peak resolution, and the availability of mass-labeled standards. Toxaphene method advancements include the application of new capillary gas chromatographic (GC) stationary phases, mass spectrometry (MS), especially ion trap MS, and the availability of Standard Reference Materials that are value-assigned for total toxaphene and selected congener concentrations. An area of promise for the separation of complex mixtures such as PCNs and toxaphene is the development of multidimensional GC techniques. The need for continued advancements and efficiencies in the analysis of contaminants such as PCNs and toxaphene remains as monitoring requirements for these compound classes are established under international agreements.

Development of a reference dose for the persistent congeners of weathered toxaphene based on in vivo and in vitro effects related to tumor promotion

Toxaphene is a mixture of chlorinated camphenes and bornanes that was produced and used in the United States until 1982. 1.3 million tons of toxaphene have been released worldwide. "Technical" toxaphene (TT) consists of a mixture of up to 800 different chemicals, known as congeners. TT weathers in the environment by both biotic and abiotic processes. The human body burden of toxaphene consists of only five persistent congeners that are not metabolized; three of these occur in considerably greater amounts than the other two. Because of the rapid metabolism and excretion of the non-persistent congeners, the persistent congeners that make up the human body burden most likely play a role in eliciting any potential adverse effects. EPA's toxicity assessment for TT is based on the occurrence of liver cancer in rodents, and considerable doubt exists whether this assessment is applicable to weathered toxaphene (WT). Using experimental results from European Union scientists, a reference dose (RfD) was developed for WT based on the three most persistent congeners that comprise the human body burden. The critical effect chosen was tumor promotion and this endpoint is considered protective for other endpoints as well. Although RfDs are typically derived for non-carcinogenic effects, the endpoint of tumor promotion is appropriate for RfD development because the experimental data suggest a dose threshold. The RfD for weathered toxaphene represented by the sum of the three major persistent congeners ( summation 3PC) is 2E-05 mg/kg-day. To apply this reference dose to a particular WT mixture, information is needed regarding the percentage of summation 3PC in the mixture.

Structure of the toxaphene compound 2,5-endo,6-exo,8,9,9,10,10-octachlorobornene-2: a temperature-dependent formation of two rotamers

The irradiation of 2,2,3-exo,5-endo,6-exo,8,9,9,10,10-decachlorobornane in n-hexane at 254 nm leads to a spontaneous Cl2 elimination as the major reaction pathway. This results finally in the main product 2,5-endo,6-exo,8,9,9,10,10-octachlorobornene-2, of which the structure could be elucidated with the help of X-ray, 1H and 13C NMR, IR, and MS. Temperature-dependent 1H NMR spectroscopic investigations have shown that the -CHCl2 groups located at C1 and C7 are able to rotate slowly under normal circumstances. If such measurements, however, are exerted at low temperatures (-10 to -60 degrees C), so can be seen that two rotamers are formed due to the hindrance of the free rotation about the bonds C1-C10, C7-C8, and C7-C9, which for the first time could be revealed for a toxaphene compound. Furthermore, as all 1H NMR chlorobornane spectra known so far show only sharp and clear signals, it can be assumed that chlorobornane compounds as main toxaphene components have fixed bonds, which requires to indicate chlorine atoms within the tentacles such as "a", "b", and "c" for characterizing the correct position. Those fixed tentacles are probably the reason that many toxaphene congeners remain very stable in environmental compartments, and particularly the biotic and abiotic transformation may strongly be hindered by the inflexibility of the tentacles.

Genotoxic activity of a technical toxaphene mixture and its photodegradation products in SOS genotoxicity tests

Toxaphene (CAS No. 800-35-2) is a complex mixture of several hundred components that was used worldwide primarily as an agricultural pesticide with insecticide effects in the second half of the 20th century. In vitro investigations of the genotoxicity and mutagenicity of toxaphene were generally described in the literature, but they provided somewhat equivocal results. We re-evaluated the genotoxicity of technical toxaphene in two prokaryotic systems. The SOS Chromotest showed high sensitivity to toxaphene: three concentrations (40, 20 and 10 mg/l) were clearly positive and the dose-response effect was evident. In the umuC assay, a dose-dependent increase in genotoxic activity was observed at toxaphene concentrations from 2.5 to 40.0 mg/l, but these results were found to be not significant. The genotoxicity of toxaphene and its photodegradation products after UV-irradiation (3-6-9 h) at concentrations ranging from 7.5 to 60.0 mg/l was also examined in this study. An irradiated solution of technical toxaphene after 3 h showed no significant evidence of bacterial growth inhibition. However, exposure of Salmonella to 6 h UV-irradiated toxaphene showed a toxic effect compared with the negative control. After 9 h irradiation, a decrease of bacterial growth was observed. Activity of beta-galactosidase in the presence of a toxaphene solution was significantly increased after 6 and 9 h irradiation, reaching values that were 2.4- and 3.1-fold higher, respectively, than the control, which exceeded the criteria of significant genotoxicity. These results show that while technical toxaphene is a weak, direct-acting mutagen in some bacterial tests, a dose-dependent toxicity and genotoxicity of its photoproducts could be conclusively demonstrated by the umuC test.

Baseline survey of concentrations of toxaphene congeners in fish from European waters

The European Union project "Investigation into the monitoring, analysis and toxicity of toxaphene"(MATT) began in 1997 involving participants from the Netherlands, Ireland, Norway and Germany. Concentration information, analytical methodology and statistical interpretation of 207 samples covering 23 different fish species from European waters are presented for three toxaphene indicator congeners: CHBs 26, 50 and 62 (CHB = chlorobornane). Concentrations for the Sigma3CHBs were more elevated in fish from more northern latitudes, such as the Barents and Norwegian Sea, compared to fish from Irish, Dutch and German waters. Concentrations were lowest in shellfish and in fish species having low lipid content and were highest in medium/high lipid species. Females from a number of fish species were shown to contain significantly higher concentrations than those observed in male fish. Overall no samples were shown to exceed existing German MRL legislation, with only one Greenland halibut sample shown to exceed Canadian TDI recommendations.

Effects elicited by toxaphene in the cynomolgus monkey (Macaca fascicularis): a pilot study

Toxaphene, which was added to glycerol/corn oil, was administered at a level of 1 mg/kg body weight/day in gelatin capsules to four healthy young adult cynomolgus (Macaca fascicularis) monkeys for 52 weeks. Four control monkeys ingested capsules containing only glycerol/corn oil. Each group had two males and two females. On a daily basis, each monkey's feed and water consumption was determined, its health was monitored and the females were swabbed to evaluate menstrual status. On a weekly basis, each monkey's body weight was determined and a detailed clinical evaluation was performed. At 4-week intervals, blood samples were taken for serum biochemistry, haematology and toxaphene analysis. Also, a local anaesthetic was administered to the nuchal fat pad area of each monkey, and adipose samples were obtained for toxaphene analysis. 1 day prior to the biopsies, a 24-h urine and faecal collection was obtained for toxaphene analysis. After 34 weeks of treatment, the immune system of the monkeys was evaluated. After 52 weeks of dosing, all treated and two control animals were necropsied. Liver samples were obtained and microsomal fractions were prepared immediately. A portion of liver and kidney was taken for toxaphene analysis. All of the major internal organs were weighed and bone marrow evaluations were conducted. Organ and tissue samples were fixed in 10% formalin and processed for light microscopy. There was no effect of treatment on body weight gain, feed consumption, water consumption or haematological parameters. Two major clinical findings were inflammation and/or enlargement of the tarsal gland and impacted diverticulae in the upper and lower eye lids. At necropsy, the relative spleen and thymus weights were greater for the treated monkeys than the controls. Toxaphene administration produced an increase in metabolism of aminopyrene, methoxyresorufin and ethoxyresorufin, three substrates that are altered specifically by cytochrome P450-based hepatic monooxygenase enzymes. Histopathological examination of tissues was unremarkable by light microscopy. Tissue analysis for toxaphene and immunology findings have been published elsewhere.

An historical record of toxaphene and its congeners in a remote lake in western Europe

Historical trends in the concentrations of toxaphene, its component homologue groups, and individual chlorobornane congeners were determined in a dated sediment core from a mountain lake, Lochnagar, in Scotland, U.K., representing the first such profiles outside of North America. The profile of total toxaphene showed a bimodal distribution with maxima in the mid-1970s and early 1990s unlike the unimodal PCB profile (maximum 1973) in the same core. The earlier toxaphene peak shows agreement with the U.S. source curve and therefore may correspond to modeled global patterns while the later peak may be dueto long-rangetransportfrom eastern and southern Europe or from still lower latitudes. Sediment toxaphene concentrations (14 ng/g dry wt (dw) at surface; 40 ng/g dw at maximum) and accumulation rates (surface 0.42 ng cm(-2) yr(-1); maximum 1.6 ng cm(-2) yr(-1)) were considerably higher than levels in untreated sites in the Great Lakes region and the Canadian Arctic and are equivalent to those reported for the Great Lakes themselves where there have been additional riverine inputs. Two toxaphene congeners, B6-923 and B7-1001, accounted for most of the hexa- and heptachlorobornanes, respectively. B6-923 and B7-1001 abundance ratios (relative to the sum of 12 chlorobornane congeners) had doubling times of 17 +/- 3 and 12 +/- 3 yr, respectively. Given the remoteness of the site from areas of toxaphene production and usage, the high sediment levels raise concerns over toxaphene levels in areas of Europe closer to sources, especially where sites are fished for human consumption. Further European data are needed for comparison.

A pharmacokinetic model for predicting absorption, elimination, and tissue burden of toxaphene in rats

A two-compartment pharmacokinetic model was formulated to predict absorption, elimination, and tissue burden of toxaphene in rats. The model was constructed based on the database of Crowder and Dindal (Bull. Environ. Contam. Toxicol. 12, 320-327, 1974) and included six tissue compartments: blood, brain, liver, muscle, fat, and carcass. The pharmacokinetically based dosimetry indicated that absorption of toxaphene was fast in fat, whole body, carcass, and blood, relatively slow in liver and muscle, and slow in brain. In contrast, the elimination rate was rapid in whole body, muscle, and blood, moderate in carcass and brain, and slow in liver and fat. Tissue burden was highest in fat, whole body, and blood, intermediate in liver, and lowest in brain. The model performance was evaluated by the data set of Pollock and Hillstrand (J. Environ. Sci. Health B 17, 635-648, 1982) on toxaphene absorption and elimination in pregnant rats. Validity of the model was confirmed by the close agreement between the predicted and observed tissue burdens of toxaphene in target tissues. Disposition of toxaphene via feces was a dominant excretory pathway while urinary excretion was a minor elimination route in male rats. However, for pregnant rats, excretion of toxaphene both in urine and feces were of similar magnitude. These characteristics of elimination are valuable for understanding the metabolism of toxaphene in pregnant rats. The model serves as a starting point for a quantitative, mechanism-based understanding of the processes that influence the pharmacokinetics of toxaphene in mammalian systems.

Induction of micronuclei in vitro by organochlorine compounds in beluga whale skin fibroblasts

Beluga whales (Delphinapterus leucas) inhabiting the St. Lawrence estuary are highly contaminated with environmental pollutants and have a high incidence of cancer. Environmental contaminants may be partly responsible for the high cancer incidence observed in this population. DNA damage plays an important role in the development of cancer. The micronuclei (MN) assay was used to test the genotoxic potential of organochlorine (OC) pesticides with and without external metabolic factor in skin fibroblasts of an Arctic beluga whale. Toxaphene, chlordane and p,p'-DDT induced significant (p<0. 05) concentration-response increases of micronucleated cells (MNCs). Statistically significant increases in MNCs, ranging from 1.7- to 5-folds when compared to control cultures, were observed for 0.05, 0. 5, 5 and 10 microg/ml toxaphene, 2, 5 and 10 microg/ml chlordane and 10 and 15 microg/ml p,p'-DDT. Presence of exogeneous metabolic factor (S9) completely abolished the MN induction potency of chlordane and p,p'-DDT, and toxaphene induced MN formation at higher concentrations (0.5 microg/ml) than without S9 mix. The ecotoxicological significance of MN induction by low concentrations of toxaphene is unknown and do not imply that toxaphene is involved in the etiology of cancer in St. Lawrence beluga whales. However, because of the known genotoxicity of toxaphene and the long lifespan of beluga whales, it cannot be excluded that toxaphene may pose a long-term genetic hazard to the more contaminated whales of this population.

Toxaphene in the Great Lakes

This paper presents the most current data for toxaphene in the water, sediments, and biota of the Laurentian Great Lakes of North America. Concentrations in water range from 1.1 ng/L in Lake Superior to 0.17 ng/L in Lake Ontario. Lake Superior has the highest water concentration, which is contrary to the pattern seen for other pollutants. The observed log particle-water partition coefficient was 4.5. Recent sediments had similar concentrations among the lakes (approx. 15 ng/g dry weight), but different homolog compositions. The log bioaccumulation factors (BAFs) normalized to lipid or organic carbon were 5.8, 6.5, 6.3, 6.7, 6.7, and 7.0 for phytoplankton, net zooplankton, Mysis, Bythotrephes, sculpin, and lake trout. These data clearly show that toxaphene biomagnifies in the foodweb.

In vitro investigation of toxaphene genotoxicity in S. typhimurium and Chinese hamster V79 lung fibroblasts

The polychlorinated pesticide toxaphene has been identified as a persistent environmental contaminant and is of particular concern in the Great Lakes and Arctic regions of Canada. Inconsistencies in published in vitro genotoxicology studies have hindered risk assessments of toxaphene exposure. When toxaphene mutagenicity was re-evaluated in the Ames Salmonella/microsome assay at 10-10,000 microg/plate, a dose-dependent increase in His revertants occurred in all five strains of S. typhimurium tested (TA97, TA98, TA100, TA102 and TA104) with higher mutation frequencies observed in the absence of S9 metabolic activation. However, the mutagenic potential of toxaphene was relatively low with concentrations greater than 500 microg/plate required to induce mutation. Toxaphene genotoxicity was also examined in a mammalian system using Chinese hamster V79 lung fibroblasts with metabolic activation provided by human HepG2 hepatoma cells. Genotoxicity of 1-10 microg/ml toxaphene was examined by measuring the frequency of sister chromatid exchange (SCE) and mutation induction at the hypoxanthine guanine phosphoribosyl transferase (HGPRT) gene locus. Although small increases in SCE were observed at toxic concentrations of toxaphene approaching the LD50 (10 microg/ml), they were not found to be statistically significant relative to control. Toxaphene was also unable to induce HGPRT mutagenesis at the concentrations tested. These results show that while toxaphene is a weak, direct-acting mutagen in the Ames Salmonella Test, convincing evidence of dose-dependent SCE induction and mutagenicity at the HGPRT gene locus could not be demonstrated in V79 cells.

Mutagenic and carcinogenic pesticides used in the agricultural environment of Gaza Strip

More than 100 metric tons of formulated pesticides (about 75 pesticides) are used annually in Gaza Strip. It was found that 19 of these pesticides, that have been used, are internationally suspended, cancelled and banned pesticides. About 1100 cases of cancer have been registered in Gaza Strip (1979-1983). The distribution of cancer types among those patients are lymphoma and hematological malignancy, breast, head and neck, gastrointestinal malignancy, reproductive system, urinary system, soft tissue tumors, brain tumors and others. Consequently, the introduction and heavy use of pesticides and other toxic substances in the Gaza Strip environment is suspected to correlate with the growing incidence of cancer and other abnormalities in the nation. Precise determination of the effects of chronic exposure is, therefore, urgently needed.

Biochemical studies of promoters of carcinogenesis in rat liver

Adult female rats were orally dosed with 1/5 to 3/5 the published LD50 of either promoters or putative promoters of carcinogenesis [hexachlorobenzene (HCB), alpha-hexachlorocyclohexane (alpha-HCH), kepone and toxaphene] or noncarcinogens [coumaphos, EDTA, caprolactam, 8-hydroxyquinoline, titanium (IV) oxide, sodium diethyldithiocarbamate (DEDTC), and sucrose] at 21 and 4 h before sacrifice. The promoters selected in this study were all of the halogenated hydrocarbon class. At doses of 1/5 to 3/5 the LD50, all four promoters or putative promoters induced rat hepatic ODC activity. The seven noncarcinogens produced several biochemical effects at doses of 1/5 the LD50: increased serum alanine aminotransferase activity (SGPT) (caprolactam and DEDTC), decreased hepatic cytochrome P-450 content (DEDTC), and increased hepatic ODC activity (8-hydroxyquinoline and DEDTC). None of the seven noncarcinogens caused hepatic DNA damage or coordinate induction of hepatic ODC and cytochrome P-450. The results support the interpretation that several of these biochemical parameters are useful in distinguishing potential tumor promoters and noncarcinogens.

An evaluation of Salmonella (Ames) test data in the published literature: application of statistical procedures and analysis of mutagenic potency

We searched the published literature for Salmonella test data on some 450 chemicals. Only 137 of more than 400 articles containing original data satisfied minimum criteria for a quantitative analysis [1751 experiments, comprising data on 152 chemicals (Table 1)]. Many of these papers did not report basic information about the test protocol (Table 2). We used previously described statistical procedures (Bernstein et al., 1982) to estimate the initial slopes of the dose-response curves and corresponding standard errors. We also applied tests for significance and linear goodness-of-fit. We then used the results of these analyses to examine several issues: (1) Linearity of the low dose region of the dose-response curve. We found that the overwhelming majority of curves were linear, though ability to detect non-linearity of dose-response curves in the standard plate test is only limited. 7% of all experiments to which the goodness-of-fit test was applied were curves of increasing slope, and with a few possible exceptions, these were not obviously associated with any particular mutagens, even those generally considered to produce non-linear effects such as MNNG and EMS (Table 3). (2) Performance of the statistical test for significance. Results of the statistical test for significance of the dose-response were compared with author's opinions as to positivity. In almost all cases (94%) results of the statistical test and authors opinions were the same. In the examples of conflicting opinions, the reasons were: (a) the statistical test places more weight than do most authors on the presence of a linear dose-response; (b) most authors tend to require at least a 2-fold increase over the spontaneous background for 'significance', and (c) when the number of spontaneous revertants is small (e.g., TA1537), authors tend to require a larger increase in induced revertants than when the spontaneous background is large, whereas the statistical procedure makes no such distinction. These factors result in the statistical test tending to identify more experiments as positive than do authors, provided there is a linear dose-response, and authors tending to judge more experiments as positive when the dose-response is not linear. (3) Reproducibility. Among the 1751 experiments there were 122 data-sets (a total of 333 experiments) in which the same chemical was tested by two or more different laboratories under the same protocol. 21 of the 122 data-sets had some disagreement between experiments as to whether results were positive or negative (Table 4).(ABSTRACT TRUNCATED AT 400 WORDS)

Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases

The human diet contains a great variety of natural mutagens and carcinogens, as well as many natural antimutagens and anticarcinogens. Many of these mutagens and carcinogens may act through the generation of oxygen radicals. Oxygen radicals may also play a major role as endogenous initiators of degenerative processes, such as DNA damage and mutation (and promotion), that may be related to cancer, heart disease, and aging. Dietary intake of natural antioxidants could be an important aspect of the body's defense mechanism against these agents. Many antioxidants are being identified as anticarcinogens. Characterizing and optimizing such defense systems may be an important part of a strategy of minimizing cancer and other age-related diseases.

Studies on the tissue disposition and fate of [14C]toxaphene in Japanese quail

The disposition and the fate of a [14C]toxaphene preparation was studied in adult and juvenile female Japanese quail. The distribution of [14C]toxaphene in the body is dominated by high concentrations of radioactivity in the adipose tissue and the egg yolk, and, especially in juvenile birds, in the bone marrow. The [14C]toxaphene compounds present in the fat tend to be less polar than the parent [14C]toxaphene. More than half of the radioactive dose is excreted via the droppings, eggs, and preen gland within a few days, with biliary excretion playing a major role. The main part of the radioactivity in feces and urine consists of water soluble compounds, a part of which is indicated to be glucuronide and sulfate conjugates, but other metabolites are probably also present. A possible connection between the toxaphene residues in the bone and the known toxaphene induced osteomalacia in birds is discussed.

Rat hepatic microsomal enzyme induction by pretreatment with toxaphene and toxaphene fractions

The levels of hepatic microsomal induction caused by toxaphene were determined. Young Sprague-Dawley rats (70 g) were administered toxaphene (ip injection, daily for 5 d) at 0, 5, 25, and 100 mg/kg. All doses caused increases in liver/body weight ratio, cytochrome P-450 level, aminopyrine demethylation, and aldrin epoxidation. The aldrin epoxidase activity increased almost 700% at the 100-mg/kg dose. Toxaphene was separated into nonpolar (S-A) and polar (S-B) fractions and administered as before at 25 mg/kg. All treatments caused significant increases in cytochrome P-450, aminopyrine demethylation, and aldrin epoxidation. A comparison of the treatments, however, did not reveal any significant differences between the treatments.

Cytokinetic and cytogenetic effect of agricultural chemicals on human lymphoid cells in vitro. II. Organochlorine pesticides

Human lymphoid cells of LAZ-007 cell line, incubated with 10(-4) to 10(-6) molar of eight different organochlorine pesticides had dose related cytotoxicity, mitotic depression and cell cycle traverse inhibition. In cultures incubated with 10(-4) M concentrations, M1 metaphases were as high as 13% (Dicofol) as compared to less than 1% in the controls. The frequency of M3 metaphases in cultures incubated with 10(-6) M concentrations ranged from 11% (Chlordane) to 15% (Endosulfan) compared to 17% in control cultures. Statistically significant increase in SCE frequency was seen in cells exposed to Chlordane, Dicofol, Endosulfan and Toxaphene. On metabolic activation with rat liver microsomal S-9 enzymes, Chlordane, Dicofol and Tetradifon induced SCE frequency was higher than that of nonactivated cultures.

The elimination, distribution, and metabolism of 14C-toxaphene in the pregnant rat

Pregnant Sprague-Dawley rats were orally administered 14C-toxaphene in olive oil on day 15 of pregnancy and housed in glass metabolism cages. Urine, feces, and tissues were collected and assayed for radioactivity. The elimination was similar to that in virgin females with the majority of activity excreted in the feces (38.4%; five days) and less in the urine (23.7%; five days). The fetuses contained the lowest levels of radioactivity of all tissues tested (28 ppb; five days) and fat contained the highest levels (7476 ppb; five days). A comparison of the activity in the fetuses with that in the dam's fat showed slight differences, indicating the presence of more polar compounds (perhaps metabolites).

Identification and quantitative determination of chlorinated pesticides

Identification and Quantitative determination of complex mixtures of chlorinated hydrocarbon pesticides and their metabolites usually require highly expensive analytical instruments and highly trained personnel. The present work describes a simplified procedure for analysis of these mixtures involving a combination of marker dye TLC and capillary column GLC.

Environmental pollution and pregnancy: risks and uncertainties for the fetus and infant

Numerous environmental contaminants can affect the developing embryo, fetus, or infant. This essay explores such questions as these: What is the importance in mutagenesis and teratogenesis of macroenvironmental pollutants such as the heavy metals, dioxin derivatives, polychlorinated diphenyl compounds, and pesticides? What is the significance of microenvironmental pollutants (or social environmental factors) such as tobacco smoke, alcohol, and pharmacologic agents over which exposed individuals have considerable control? What are some of the ethical and legal implications of these toxins of which clinicians should be aware?

Identifying environmental chemicals causing mutations and cancer

Damage to DNA appears to be the major cause of most cancer and genetic birth defects and may contribute to aging and heart disease as well. The agents that cause this damage must be identified. Many of these agents are natural chemicals present in the human diet as complex mixtures. The tens of thousands of man-made chemicals that have been introduced into the environment in the last few decades must also be tested for their ability to damage DNA. Existing animal tests and human epidemiology alone are inadequate for this task because of time, expense, and the difficulty of dealing with complex mixtures, Newly developed short-term tests, most of them assaying for mutagenicity, are discussed as key tools in identifying environmental mutagens and carcinogens.